Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoHealth (GOCO) Other Operating Expenses (2019 - 2025)

GoHealth (GOCO) has disclosed Other Operating Expenses for 7 consecutive years, with $86.6 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 53.81% to $86.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $717.0 million through Dec 2025, up 42.99% year-over-year, with the annual reading at $649.1 million for FY2025, 29.45% up from the prior year.
  • Other Operating Expenses hit $86.6 million in Q4 2025 for GoHealth, down from $284.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $558.0 million in Q4 2021 to a low of $86.6 million in Q4 2025.
  • Historically, Other Operating Expenses has averaged $188.1 million across 5 years, with a median of $159.4 million in 2022.
  • Biggest five-year swings in Other Operating Expenses: tumbled 79.96% in 2022 and later soared 197.57% in 2023.
  • Year by year, Other Operating Expenses stood at $558.0 million in 2021, then crashed by 79.96% to $111.8 million in 2022, then surged by 197.57% to $332.7 million in 2023, then crashed by 43.64% to $187.5 million in 2024, then plummeted by 53.81% to $86.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for GOCO at $86.6 million in Q4 2025, $284.4 million in Q3 2025, and $163.3 million in Q2 2025.